维普中文期刊产品整合服务
241篇 您的检索式:作者名="HASHASH"
    题名 作者 年代 出处 被引量
1Lessons in bridge damage learned from the Wenchuan earthquake显示文摘A strong earthquake occurred in Wenchuan County,Sichuan Province,China,on May 12,2008.Shortly after the earthquake,the Turner-Fairbank Highway Research Center of the Federal Highway Administration,in partnership with the Research Institute of Highways,the Ministry of Communication of China,led a reconnaissance team to conduct a post-earthquake bridge performance investigation of the transportation system in the earthquake affected areas.The U.S.transportation system reconnaissance team visited the area during July 20-24,2008.This paper presents the fi ndings and lessons learned by the team.W. Phillip Yen Genda Chen Mark Yashinski Youssef Hashash Curtis Holu Wang Kehai GuoXiaodong 2009Earthquake Engineering and Engineering Vibration2009,8,2:11
2Seismic design and analysis of underground structures显示文摘Youssef M.A. Hashash Jeffrey J. Hook Birger Schmidt John I-Chiang Yao 2001Tunnelling and Underground Space Technology incorporating Trenchless Technology Research2001,,4:6
3A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease显示文摘AIM:To compare the efficacy of the proton-pump inhibitor,rabeprazole,with that of the H 2-receptor antagonist,ranitidine,as on-demand therapy for relieving symptoms associated with non-erosive reflux disease(NERD).METHODS:This is a single center,prospective,randomized,open-label trial of on-demand therapy with rabeprazole(group A) vs ranitidine(group B) for 4 wk.Eighty-three patients who presented to the American University of Beirut Medical Center with persistent gastroesophageal reflux disease(GERD) symptoms and a normal upper gastrointestinal endoscopy were eligible for the study.Patients in group A(n = 44) were allowed a maximum rabeprazole dose of 20 mg twice daily,while those in group B(n = 39) were allowed a maximum ranitidine dose of 300 mg twice daily.Efficacy was assessed by patient evaluation of global symptom relief,scores of the SF-36 quality of life(QoL) questionnaires,total number of pills used,and number of medication-free days.RESULTS:Among the 83 patients who were enrolled in the study,76 patients(40 in the rabeprazole group and 36 in the ranitidine group) completed the 4-wk trial.Baseline characteristics were comparable between both groups.After 4 wk,there was no significant difference in the subjective global symptom relief between the rabeprazole and the ranitidine groups(71.4% vs 65.4%,respectively;P = 0.9).There were no statistically significant differences between mean cumulative scores of the SF-36 QoL questionnaire for the two study groups(rabeprazole 22.40 ± 27.53 vs ranitidine 17.28 ± 37.06;P = 0.582).There was no significant difference in the mean number of pills used(rabeprazole 35.70 ± 29.75 vs ranitidine 32.86 ± 26.98;P = 0.66).There was also no statistically significant difference in the mean number of medication-free days between both groups.CONCLUSION:Rabeprazole has a comparable efficacy compared to ranitidine when given on-demand for the treatment of NERD.Both medications were associated with improved quality of life.Abdallah A Kobeissy Jana G Hashash Faek R Jamali Assaad M Skoury Reham Haddad Sarah El-Samad Rami Ladki Rola Aswad Assaad M Soweid 2012World Journal of Gastroenterology2012,18,19:4
4Seismic design and analysis of underground structures显示文摘Youssef M.A. Hashash Jeffrey J. Hook Birger Schmidt John I-Chiang Yao 2001Tunnelling and Underground Space Technology incorporating Trenchless Technology Research2001,,4:4
5Seismic design and analysis of underground structures显示文摘Hashash T M A Hook J J Schmidt B Yao J I 2001Tunnelling and Underground Space Technology2001,16,4:2
6Some Reaction with Arylidene Malonic Acid and Diethl Arylidene Malonate 显示文摘Mohamed M M Hashash M A Kady M Y 1980Rev Roum Chim1980,25,2:2
7The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis显示文摘Mohamad A. Hanouneh Ibrahim A. Hanouneh Jana G. Hashash Ryan Law Jamak Modaresi Esfeh Rocio Lopez Nyla Hazratjee Thomas Smith Nizar N. Zein 2012Journal of Clinical Gastroenterology2012,,8:2
8Celiac disease in Middle Eastern and North African countries:A new burden?显示文摘Celiac disease(CD) is now recognized as a common disorder among Middle Eastern(ME) and North African(NA) populations.The aim of this review is to assess the available data regarding CD in the ME and NA and to compare this information with that of Western countries.A literature review was performed using the electronic databases PubMed and Medline(1950-2008) as search engines,and 'celiac disease' was used as a Mesh term.The search was limited to ME and NA countries.The prevalence of CD in ME and NA countries among low risk populations is similar to that of Western countries,but is higher in high risk populations such as those with type 1 diabetes.It is underestimated because of lack of clinical suspicion and lack of patient awareness.Clinical presentations in term of gastrointestinal,hematologic,skeletal,and liver manifestations are similar between both populations except for a high prevalence of short stature in some ME and NA countries.Few studies have addressed atypical or silent CD.As in the West,diagnosis is initially made by serological tests and is confirmed by small intestinal biopsies.Gluten-free diet is the main mode of treatment with a higher apparent adherence rate than in the West.Most disease complications result from malabsorption.The disease is strongly associated with HLA DQ2 and to a lesser extent with HLA DQ8 alleles.In conclusion,CD prevalence is underestimated,with little data available about its malignant complications.Disease parameters in the ME and NA are otherwise similar to those in Western countries.Kassem Barada Abbas Bitar Mohamad Abdul-Razak Mokadem Jana Ghazi Hashash Peter Green 2010World Journal of Gastroenterology2010,16,12:2
9Mechanisms of load transfer and arching for braced excavation in clay显示文摘Hashash Y M A Whittle A J 2002Journal of Geotechnical and Geoenvironmental Engineering ASCE2002,128,3:1
10Characterisation of Pgal, a putative Candidaalbicans cell wall protein necessary for proper adhesion and bio-film formation显示文摘Hashash R Younes S Bahnan W E1 Koussa J Maalouf K’Di-massi H I 2011Mycoses2011,54,:1
11Seismic design and analysis of underground structures 显示文摘Hashash Y M A Hook J J Schmidt B 2001Tunnelling and Under- ground Space Technology2001,16,4:1
12Clinical trial:a randomized controlled cross-over study of flupenthixol + melitracen in functional dyspepsia显示文摘Hashash JG Abdul-Baki H Azar C 2008Aliment Pharmacol Ther2008,27,11:1
13Clinical trial:a randomized controlled cross-over study of flupenthixol+melitracen in functional dyspepsia显示文摘Hashash JG Abdul-Baki H Azar C 2008Aliment Pharmacol Ther2008,27,11:1
14Seismic Design and Analysis of Underground Structure 显示文摘HASHASH Y M A HOOK J SCHMIDT B 2001Tunneling and Underground Space Technology2001,16,4:1
15Clinical trial:a ran- domized controlled cross-over study of flupenthixolq-melitracen in functional dyspepsia显示文摘Hashash JG Abdul-Baki H Azar C etal 2008Aliment Pharmacol Ther2008,27,11:1
16Comparison of two inverse analysis techniques for learning deep excavation response显示文摘HASHASH Y M A LEVASSEUR S OSOULI A 2010Computers and Geotechnics2010,37,3:1
17Simulation of front end loader bucket-soil interaction显示文摘NEZAMI Erfan G HASHASH Youssef M A ZHAO Dawei 2007International Journal for Numerical and Analytical Methods in Geomechanics2007,31,9:1
18Contact interface in seismic analysis of circular tunnels 显示文摘Sedarat H Kozak A Hashash Y 2009Tunnelling and Underground Space Technology2009,24,4:1
19Generalized strain probing of constitutive models显示文摘HASHASH Y M A FU Q w BUTKOUICH J 2004International Journal for Numerical and Analytical Methods in Geomechanics2004,28,:1
20Seismic design and analysis of underground structures显示文摘HASHASH Y M A HOOK J J SCHMIDT B 0,,04:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费